Institute of Personalized Medicine (IPM)
Pharmacogenomics aims at understanding how variations in the human genome affect the response to medications.
Our researchers are working to generate new knowledge, and to develop tools and algorithms that can help in personalizing medicine utilizing a patient’s genetic profile and other factors to achieve maximum therapeutic benefit with minimum toxicity.
News
Pharmacogenomics Conference 2020
The third biennial pharmacogenomics conference will take place over two days, June 11-12, 2020. The conference will provide PGx implementation education on a range of topics through lectures and smaller group breakout sessions. Registration opens on January 15, 2020.
Cindy Luo
Pamala Jacobson received the Sara Evans Faculty Woman Scholar/ Leader Award from the University of Minnesota Women’s Center, Office for Equity and Diversity and was honored at their Celebrating Changemakers Awards event on October 11, 2018.
This session highlighted the social and cultural challenges associated with providing care to local Native American tribes in Minnesota, who face larger health disparities than other populations.
David Stenehjem works in the rapidly growing field of outcomes research, which guides his research on midostaurin in FLT3-mutated acute myeloid leukemia.
Weekly Genomics Scan
This weekly update features emerging roles of human genomics, testing and interventions in a wide variety of noncommunicable diseases across the life span.
Precision Medicine Seminar Series
"Bringing Genomics to the Front Lines of Care: The NorthShore Experience"
Henry "Mark" Dunnenberger, PharmD
Director of Pharmacogenomics, Mark R. Neamann Center for Personalized Medicine at NorthShore University Health System
Thursday, October 3
2 PM - 3 PM 2-650 Moos Tower
Dr. Henry “Mark” Dunnenberger is Director of Pharmacogenomics in the Mark R. Neamann Center for Personalized Medicine at NorthShore University HealthSystem, and leads the various clinical genomics implementation projects within the Center for Personalized Medicine. Dr. Dunnenberger leads the Pharmacogenomics Clinic, which pre-emptively screens patients for responses to medications based on genetic makeup.
This event is free and open to the public. Light refreshments will be served.
Pharmacogenomics
Conference
Genomic Testing to Individualize Drug Therapy
The 2018 Pharmacogenomics Conference on June 22 was at capacity with over 310 registrants in attendance. Topics included: cancer somatic mutations and selection of targeted therapies, emerging PGx areas. Read about the event here.
University Precision Medicine Initiatives
Precision Medicine and Health Consortium (PMHC)
Bringing together scientists, healthcare providers, patients and payers in the area of precision medicine to promote research, education and the use of precision medicine and health to improve human health.
Minnesota Precision Medicine Collaborative (MPMC)
Transforming health and advancing equity by generating precision treatments of disease to advance health outcomes for all Minnesotans.